secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aardvark Therapeutics, Inc. (AARD)
CIK:        0001774857
Form:       8-K
Filed at:   2026-08-17T20:10:31+00:00
Accession:  0001193125-26-354053
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aardvark Therapeutics annual meeting: directors elected, BDO ratified, option repricing approved
--------------------------------------------------------------------------------

- Victor Tong Jr. and Jeffrey Chi elected as Class I directors; Tong received 6,264,929 votes for, Chi 6,426,038.
- BDO USA ratified as independent auditor for FY2026 with 11,877,567 votes for.
- Stock option repricing under 2017, 2025, and 2025 Inducement Plans approved with 4,649,269 for, 3,439,983 against.
- Quorum of 54.79% of outstanding shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526354053/0001193125-26-354053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526354053/ck0001774857-20260814.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-354053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer